🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluated the persistence of immunity following primary typhoid ...
Status
Completed
Location
Schiphra Protestant Hospital
Start Date
2024-08-17
Trial ID
NCT07624175
Treatments Being Tested
Primary objectives: * To assess the safety profile of each SP0202 formulat...
Status
Completed
Location
The Children's Clinic Of Jonesboro PA Site Number : 8400143
Start Date
2020-05-22
Trial ID
NCT04398706
Treatments Being Tested
This cluster randomised trial will examine the impact of introducing TyphiB...
Status
Completed
Location
Christian Medical College Vellore
Start Date
2023-05-01
Trial ID
NCT05500482
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity and the kinetic...
Status
Completed
Location
Centre for the Evaluation of Vaccination (CEV)
Start Date
2011-10
Trial ID
NCT01438996
Treatments Being Tested
Using an established model of human typhoid infection, whereby healthy adul...
Status
Completed
Location
Centre for Clinical Vaccinology and Tropical Medicine
Start Date
2015-09
Trial ID
NCT02324751
Treatments Being Tested
The current study is a follow-up to 2 previous parent studies, a dose-selec...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-02
Trial ID
NCT07320716
Treatments Being Tested
This study compares the safety and immunogenicity profile of several travel...
Status
Completed
Location
Centrum ockovani a cestovni mediciny (Vaccination and Travel Medicine Centre) Poliklinika II
Start Date
2011-11
Trial ID
NCT01466387
This trial is aimed to evaluate the safety and immunogenicity profiles of t...
Status
Completed
Location
Center for the Evaluation of Vaccination (CEV)
Start Date
2010-10
Trial ID
NCT01193907
This study evaluates the immune response and safety of a multicomponent, 2-...
Status
Completed
Location
GSK Investigational Site
Start Date
2024-11-13
Trial ID
NCT06663436
This is an observer-blinded, comparative, single dose, clinical phase II/II...
Status
Completed
Location
De La Salle Medical and Health Sciences Institute
Start Date
2020-09-07
Trial ID
NCT04830371
Treatments Being Tested